Drug Patents owned by Corium

1. Drug name - ADLARITY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10016372 CORIUM Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
Jul, 2037

(14 years from now)

US11103463 CORIUM Methods for treating alzheimer's disease with donepezil transdermal system
Jul, 2037

(14 years from now)

US9993466 CORIUM Donepezil transdermal delivery system
Jul, 2037

(14 years from now)

US10300025 CORIUM Donepezil transdermal delivery system
Jul, 2037

(14 years from now)

US10307379 CORIUM Donepezil transdermal delivery system
Jul, 2037

(14 years from now)

US10835499 CORIUM Systems and methods for long term transdermal administration
May, 2038

(15 years from now)

US10966936 CORIUM Systems comprising a composite backing and methods for long term transdermal administration
Aug, 2038

(15 years from now)

Drugs and Companies using DONEPEZIL HYDROCHLORIDE ingredient

Market Authorisation Date: 11 March, 2022

Treatment: A method of transdermal delivery of donepezil for treating mild, moderate and severe dementia of the alzheimer's type

Dosage: SYSTEM;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
5MG/DAY SYSTEM;TRANSDERMAL Prescription
10MG/DAY SYSTEM;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.

Other things you might be interested in